SCHEMBL3935356

SCHEMBL3935356

Cc1cc(NC(=O)NCCN2CCC(N(C)S(=O)(=O)c3cc(Cl)sc3Cl)CC2)cc(C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
TP53 P04637 3/20 0.39
CNR1 P21554 3/20 0.38
KDM4E B2RXH2 1/20 0.36
UTS2R Q9UKP6 2/20 0.36
DRD2 P14416 2/20 0.35
CACNA1H O95180 1/20 0.35
CYP2D6 P10635 1/20 0.35
KCNH2 Q12809 1/20 0.35
HTR1A P08908 1/20 0.35
DRD4 P21917 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NAMPT P43490 1/20 0.35
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
ADRA2A P08913 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3557589 0.92 CNR1 (0.38) MAPTTP53CNR1KDM4EUTS2R
SCHEMBL3932204 0.91 CNR1 (0.37) MAPTTP53CNR1KDM4EUTS2R
SCHEMBL3936618 0.86 CNR1 (0.40) MAPTTP53CNR1KDM4EUTS2R
SCHEMBL3562457 0.85 HTR2A (0.53) MAPTTP53CNR1UTS2RDRD2
SCHEMBL3554924 0.83 L3MBTL1 (0.51) MAPTTP53CNR1SMN1; SMN2L3MBTL1
SCHEMBL3565446 0.83 HTR2A (0.53) MAPTTP53UTS2RDRD2HTR2A
SCHEMBL301931 0.83 CACNA1H (0.40) MAPTTP53CNR1DRD2CACNA1H
SCHEMBL3562364 0.82 L3MBTL1 (0.43) TP53CNR1SMN1; SMN2L3MBTL1NAMPT
SCHEMBL3552561 0.82 KMT2A (0.42) MAPTTP53UTS2RDRD2HTR2A
SCHEMBL301932 0.82 CNR1 (0.37) MAPTTP53CNR1UTS2RDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670470-B1 PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-04-08 EP claimed